<DOC>
	<DOCNO>NCT01666236</DOCNO>
	<brief_summary>Study effectiveness treatment detachment retinal pigment epithelium secondary polypoidal choroidal vasculopathy . Efficacy assess regression polyp area twelve month , compare baseline . Treatment study triple therapy : 1 ) reduced-fluence photodynamic therapy ( PDT ) , 2 ) intravitreal ( IVT ) triamcinolone , 3 ) IVT ranibizumab , treatment detachment retinal pigment epithelium ( PED ) secondary Polypoidal Choroidal Vasculopathy ( PCV ) .</brief_summary>
	<brief_title>Triple Treatment Detachment Retinal Pigment Epithelium Secondary Polypoidal Choroidal Vasculopathy</brief_title>
	<detailed_description />
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Dissociative Disorders</mesh_term>
	<mesh_term>Retinal Detachment</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<mesh_term>Verteporfin</mesh_term>
	<criteria>Patients PCV associate PED near polypoidal lesion recently diagnose , document FA , ICGA OCT . Visual acuity 20/40 20/400 . Patients older 50 year ( gender ) . Women must postmenopausal least 12 month surgically sterile . No previous treatment study eye . Accept sign inform consent . No condition prevent monitor patient one year . Transparent ocular medium adequate pupillary dilation allow good image fundus . Blepharitis external eye infection . Allergy ranibizumab , verteporfin , triamcinolone , fluorescein indocyanine green . Patients unable provide inform consent . Concomitant ocular disease impairs visual acuity . Any intraocular condition ( cataract Proliferative Diabetic Retinopathy ) study eye , opinion investigator , could require surgery medication followup ( 1 year ) . Active intraocular inflammation . Patients Glaucoma ocular hypertension ( IOP &gt; 25mmHg ) . Premenopausal woman . Pregnancy lactation . Effective treatment active systemic infection history recurrent infection . Evidence concomitant disease ( cardiovascular , neurological , pulmonary , renal , hepatic , endocrine gastrointestinal ) uncontrolled .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Age-Related Macular Degeneration</keyword>
	<keyword>Pigment Epithelial Detachment</keyword>
	<keyword>Polypoidal Choroidal Vasculopathy</keyword>
</DOC>